Sánchez-Fructuoso, Ana I <br/><br/>
Everolimus: an update on the mechanism of action, pharmacokinetics and recent clinical trials.  [electronic resource] 

 -  Expert opinion on drug metabolism & toxicology  Jun 2008 
 - 807-19 p.  digital 
<br/><br/> Publication Type: Journal Article; Review; Systematic Review 
<br/><br/><label>ISSN: </label>1742-5255 
<br/><br/><label>Standard No.: </label>10.1517/17425255.4.6.807  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Clinical Trials as Topic<br/>Cytomegalovirus Infections--immunology<br/>Drug Monitoring<br/>Everolimus<br/>Graft Rejection--immunology<br/>Graft Survival--drug effects<br/>Heart Transplantation<br/>Humans<br/>Immunosuppressive Agents--adverse effects<br/>Kidney Transplantation<br/>Neoplasms--drug therapy<br/>Organ Transplantation--adverse effects<br/>Sirolimus--adverse effects<br/>Treatment Outcome